201 related articles for article (PubMed ID: 12798520)
21. Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin.
Ng HJ; Koh LP; Lee LH
Ann Hematol; 2003 Apr; 82(4):257-8. PubMed ID: 12707733
[TBL] [Abstract][Full Text] [Related]
22. Successful use of recombinant factor VIIa in a patient with intractable bleeding during extracorporeal membrane oxygenation.
Brose S; Sirbu H; Engel M; Kuhlen R; Autschbach R
Thorac Cardiovasc Surg; 2005 Dec; 53(6):389-90. PubMed ID: 16311981
[TBL] [Abstract][Full Text] [Related]
23. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
[TBL] [Abstract][Full Text] [Related]
24. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of coagulation studies in predicting response to activated recombinant Factor VII in cardiac surgery patients.
Lee AI; Campigotto F; Rawn JD; Neuberg D; Kaufman RM; Berliner N
Br J Haematol; 2012 May; 157(3):397-400. PubMed ID: 22224596
[No Abstract] [Full Text] [Related]
26. Failure of recombinant FVIIa as treatment for abdominal bleeding in acquired hemophilia.
Makris M; Hampton KK; Preston EE
Am J Hematol; 2001 Jan; 66(1):67-8. PubMed ID: 11426500
[No Abstract] [Full Text] [Related]
27. Successful use of factor VIIa to control life-threatening post-operative haemorrhage in a patient on extra-corporeal membrane oxygenation.
Dunne B; Xiao P; Andrews D
Heart Lung Circ; 2012 Apr; 21(4):229-30. PubMed ID: 22036715
[TBL] [Abstract][Full Text] [Related]
28. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation.
Pepas LP; Arif-Adib M; Kadir RA
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):757-61. PubMed ID: 17018493
[TBL] [Abstract][Full Text] [Related]
29. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
Verre M; Bossio F; Mammone A; Piccirillo M; Tancioni F; Varano M
Minerva Ginecol; 2006 Feb; 58(1):81-4. PubMed ID: 16498374
[TBL] [Abstract][Full Text] [Related]
30. Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery.
Sucker C; Sabel M; Stummer W; Zotz RB; Scharf RE; Gerhardt A
Clin Appl Thromb Hemost; 2008 Oct; 14(4):472-5. PubMed ID: 18160590
[TBL] [Abstract][Full Text] [Related]
31. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII.
Hendriks HG; van der Maaten JM; de Wolf J; Waterbolk TW; Slooff MJ; van der Meer J
Anesth Analg; 2001 Aug; 93(2):287-9, 2nd contents page. PubMed ID: 11473845
[TBL] [Abstract][Full Text] [Related]
32. The use of recombinant activated factor VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm.
Wahlgren CM; Swedenborg J
Eur J Vasc Endovasc Surg; 2003 Aug; 26(2):221-2. PubMed ID: 12917843
[TBL] [Abstract][Full Text] [Related]
33. Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. Report of two cases and review of the literature.
Hartmann M; Sucker C; Messing M
J Neurosurg; 2006 Jan; 104(1 Suppl):55-8. PubMed ID: 16509483
[TBL] [Abstract][Full Text] [Related]
34. Recombinant activated factor VII following pediatric cardiac surgery.
Kylasam S; Mos K; Fijtin S; Webster B; Chard R; Egan J
J Intensive Care Med; 2009; 24(2):116-21. PubMed ID: 19188273
[TBL] [Abstract][Full Text] [Related]
35. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
36. Management of severe sphincterotomy bleeding with recombinant activated factor VII.
Garrido-Serrano A
Gastrointest Endosc; 2012 Oct; 76(4):925-6. PubMed ID: 22985655
[No Abstract] [Full Text] [Related]
37. Factor VII for excessive bleeding following congenital heart disease surgery.
Changlani DK; Devendaran V; Murmu UC; Ganesan S; Varghese R; Kumar RS
Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):120-5. PubMed ID: 22499956
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of gastrointestinal bleeding with recombinant factor VIIa after kidney transplantation in patients with pancytopenia.
Malato A; Lo Monte AI; Anastasio R; Lo Coco L; Abbene I; Maione C; Gioviale MC; Siragusa S
Transplant Proc; 2006 May; 38(4):1031-3. PubMed ID: 16757254
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease.
Friederich PW; Wever PC; Briët E; Doorenbos CJ; Levi M
Am J Hematol; 2001 Apr; 66(4):292-4. PubMed ID: 11279642
[TBL] [Abstract][Full Text] [Related]
40. Recombinant factor VIIa treatment for life-threatening haemoptysis.
Yildirim H; Ucgun I; Yalcin AU; Gulbaş Z; Sahin G; Acikalin MF; Metintas M; Ak G
Respirology; 2006 Sep; 11(5):652-4. PubMed ID: 16916342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
